Lactose (India) Limited (BOM:524202)

Market Cap	1.27B
Revenue (ttm)	1.18B
Net Income (ttm)	69.19M
Shares Out	12.59M
EPS (ttm)	5.49
PE Ratio	18.40
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,687
Average Volume	10,249
Open	108.00
Previous Close	104.25
Day's Range	100.00 - 109.20
52-Week Range	97.60 - 247.40
Beta	0.71
RSI	27.07
Earnings Date	May 30, 2025

About Lactose (India)

Lactose (India) Limited engages in the manufacture and trading of pharmaceutical products in India. The company is involved in the production of drugs, medicines, chemicals, foods, etc. It offers lactose monohydrate; dry granulated, film, and lacquer coated tablets; and pharmaceutical products in solid dose forms. In addition, the company provides disaccharide lactulose, an active pharmaceutical ingredient that is used in the treatment of constipation, hepatitis encephalopathy, intestinal microflora, dental care, diabetes, and chronic liver dis...

• Industry: Pharmaceutical Preparations
• Founded: 1991
• Employees: 129
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524202

Financial Performance

In 2023, Lactose (India)'s revenue was 1.14 billion, an increase of 73.09% compared to the previous year's 657.96 million. Earnings were 67.89 million, an increase of 461.77%.